Patent ID: 9592235
Date: 2017-03-14
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for the treatment of cancer in a patient in need thereof which method comprises administering to a patient a therapeutically effective amount of a compound of claim formula (I) and stereoisomers, geometric isomers, tautomers, or pharmaceutically acceptable salts thereof, wherein: R R R R is H or C R n is 0 or 1; wherein in the preceeding heteroaryl groups are 5 or 6 membered heteroaryls comprising 1, 2 or 3 heteroatom(s) selected from N, O or S and heterocyclyl groups are 5 to 10 membered heterocyclyls comprising 1, 2 or 3 heteroatom(s) selected from N, O or S; with the proviso that the compound of Formula I is not: 6-(3-(trifluoromethyl)phenyl)pyrido[3,2-d]pyrimidin-4-amine 6-(3-(trifluoromethoxy)phenyl)pyrido[3,2-d]pyrimidin-4-amine 6-phenylpyrido[3,2-d]pyrimadin-4-amine  or, 6-(4-fluorophenyl)pyrido[3,2-d]pyrimidin-4-amine